Albert312 Hyatt152
==================
Race:                White
Ethnicity:           Non-Hispanic
Gender:              M
Age:                 DECEASED
Birth Date:          1964-03-10
Marital Status:      M
--------------------------------------------------------------------------------
ALLERGIES:
No Known Allergies
--------------------------------------------------------------------------------
ENCOUNTER
2012-06-28 : Encounter at CAMBRIDGE PUBLIC HEALTH COMMISSION : Encounter for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
Type: inpatient
   
   MEDICATIONS:
  2012-07-11 : PACLitaxel 100 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-11 : Cisplatin 50 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-10 : PACLitaxel 100 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-10 : Cisplatin 50 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-09 : PACLitaxel 100 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-09 : Cisplatin 50 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-08 : PACLitaxel 100 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-08 : Cisplatin 50 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-07 : PACLitaxel 100 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-07 : Cisplatin 50 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-06 : PACLitaxel 100 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-06 : Cisplatin 50 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-05 : PACLitaxel 100 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-05 : Cisplatin 50 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-04 : PACLitaxel 100 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-04 : Cisplatin 50 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-03 : PACLitaxel 100 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-03 : Cisplatin 50 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-02 : PACLitaxel 100 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-02 : Cisplatin 50 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-01 : PACLitaxel 100 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-01 : Cisplatin 50 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-06-30 : PACLitaxel 100 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-06-30 : Cisplatin 50 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-06-28 : PACLitaxel 100 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-06-28 : Cisplatin 50 MG Injection for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
   
   CONDITIONS:
   
   CARE PLANS:
   
   REPORTS:
  2012-06-28 : Comprehensive metabolic 2000 panel - Serum or Plasma
           - Glucose [Mass/volume] in Blood           117.6 mg/dL
           - Urea nitrogen [Mass/volume] in Blood     11.3 mg/dL
           - Creatinine [Mass/volume] in Blood        2.6 mg/dL
           - Calcium [Mass/volume] in Blood           9.0 mg/dL
           - Sodium [Moles/volume] in Blood           143.8 mmol/L
           - Potassium [Moles/volume] in Blood        5.1 mmol/L
           - Chloride [Moles/volume] in Blood         104.3 mmol/L
           - Carbon dioxide, total [Moles/volume] in Blood 26.9 mmol/L
           - Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 19.7 mL/min
           - Protein [Mass/volume] in Serum or Plasma 6.7 g/dL
           - Albumin [Mass/volume] in Serum or Plasma 4.7 g/dL
           - Globulin [Mass/volume] in Serum by calculation 2.2 g/L
           - Bilirubin.total [Mass/volume] in Serum or Plasma 0.8 mg/dL
           - Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 56.9 U/L
           - Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24.1 U/L
           - Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 38.9 U/L
  2012-06-28 : Urinalysis macro (dipstick) panel - Urine
           - Appearance of Urine                      Cloudy urine (finding) {nominal}
           - Odor of Urine                            Urine smell ammoniacal (finding) {nominal}
           - Clarity of Urine                         Translucent (qualifier value) {nominal}
           - Color of Urine                           Brown color (qualifier value) {nominal}
           - Glucose [Mass/volume] in Urine by Test strip 1.0 mg/dL
           - Glucose [Presence] in Urine by Test strip Urine glucose test = ++ (finding) {nominal}
           - Bilirubin.total [Mass/volume] in Urine by Test strip 1.4 mg/dL
           - Bilirubin.total [Presence] in Urine by Test strip Finding of bilirubin in urine (finding) {nominal}
           - Ketones [Mass/volume] in Urine by Test strip 6.2 mg/dL
           - Ketones [Presence] in Urine by Test strip Urine ketone test = +++ (finding) {nominal}
           - Specific gravity of Urine by Test strip  1.0 {nominal}
           - pH of Urine by Test strip                6.9 pH
           - Protein [Mass/volume] in Urine by Test strip 400.1 mg/dL
           - Protein [Presence] in Urine by Test strip Urine protein test = +++ (finding) {nominal}
           - Nitrite [Presence] in Urine by Test strip Urine nitrite negative (finding) {nominal}
           - Hemoglobin [Presence] in Urine by Test strip Urine blood test = negative (finding) {nominal}
           - Leukocyte esterase [Presence] in Urine by Test strip Urine leukocyte test negative (finding) {nominal}
  2012-06-28 : CBC panel - Blood by Automated count
           - Leukocytes [#/volume] in Blood by Automated count 4.6 10*3/uL
           - Erythrocytes [#/volume] in Blood by Automated count 5.2 10*6/uL
           - Hemoglobin [Mass/volume] in Blood        15.6 g/dL
           - Hematocrit [Volume Fraction] of Blood by Automated count 37.7 %
           - MCV [Entitic volume] by Automated count  92.7 fL
           - MCH [Entitic mass] by Automated count    29.9 pg
           - MCHC [Mass/volume] by Automated count    35.9 g/dL
           - Erythrocyte distribution width [Entitic volume] by Automated count 41.4 fL
           - Platelets [#/volume] in Blood by Automated count 237.1 10*3/uL
           - Platelet distribution width [Entitic volume] in Blood by Automated count 514.6 fL
           - Platelet mean volume [Entitic volume] in Blood by Automated count 9.5 fL
   
   OBSERVATIONS:
  2012-07-11 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 9.0 {score}
  2012-07-10 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 9.0 {score}
  2012-07-09 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 6.0 {score}
  2012-07-08 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 8.0 {score}
  2012-07-07 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 9.0 {score}
  2012-07-06 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 8.0 {score}
  2012-07-05 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 9.0 {score}
  2012-07-04 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 5.0 {score}
  2012-07-03 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 5.0 {score}
  2012-07-02 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 6.0 {score}
  2012-07-01 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 9.0 {score}
  2012-06-30 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 8.0 {score}
  2012-06-28 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 6.0 {score}
  2012-06-28 : Platelet mean volume [Entitic volume] in Blood by Automated count 9.5 fL
  2012-06-28 : Platelet distribution width [Entitic volume] in Blood by Automated count 514.6 fL
  2012-06-28 : Platelets [#/volume] in Blood by Automated count 237.1 10*3/uL
  2012-06-28 : Erythrocyte distribution width [Entitic volume] by Automated count 41.4 fL
  2012-06-28 : MCHC [Mass/volume] by Automated count    35.9 g/dL
  2012-06-28 : MCH [Entitic mass] by Automated count    29.9 pg
  2012-06-28 : MCV [Entitic volume] by Automated count  92.7 fL
  2012-06-28 : Hematocrit [Volume Fraction] of Blood by Automated count 37.7 %
  2012-06-28 : Hemoglobin [Mass/volume] in Blood        15.6 g/dL
  2012-06-28 : Erythrocytes [#/volume] in Blood by Automated count 5.2 10*6/uL
  2012-06-28 : Leukocytes [#/volume] in Blood by Automated count 4.6 10*3/uL
  2012-06-28 : Leukocyte esterase [Presence] in Urine by Test strip Urine leukocyte test negative (finding) {nominal}
  2012-06-28 : Hemoglobin [Presence] in Urine by Test strip Urine blood test = negative (finding) {nominal}
  2012-06-28 : Nitrite [Presence] in Urine by Test strip Urine nitrite negative (finding) {nominal}
  2012-06-28 : Protein [Presence] in Urine by Test strip Urine protein test = +++ (finding) {nominal}
  2012-06-28 : Protein [Mass/volume] in Urine by Test strip 400.1 mg/dL
  2012-06-28 : pH of Urine by Test strip                6.9 pH
  2012-06-28 : Specific gravity of Urine by Test strip  1.0 {nominal}
  2012-06-28 : Ketones [Presence] in Urine by Test strip Urine ketone test = +++ (finding) {nominal}
  2012-06-28 : Ketones [Mass/volume] in Urine by Test strip 6.2 mg/dL
  2012-06-28 : Bilirubin.total [Presence] in Urine by Test strip Finding of bilirubin in urine (finding) {nominal}
  2012-06-28 : Bilirubin.total [Mass/volume] in Urine by Test strip 1.4 mg/dL
  2012-06-28 : Glucose [Presence] in Urine by Test strip Urine glucose test = ++ (finding) {nominal}
  2012-06-28 : Glucose [Mass/volume] in Urine by Test strip 1.0 mg/dL
  2012-06-28 : Color of Urine                           Brown color (qualifier value) {nominal}
  2012-06-28 : Clarity of Urine                         Translucent (qualifier value) {nominal}
  2012-06-28 : Odor of Urine                            Urine smell ammoniacal (finding) {nominal}
  2012-06-28 : Appearance of Urine                      Cloudy urine (finding) {nominal}
  2012-06-28 : Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 38.9 U/L
  2012-06-28 : Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24.1 U/L
  2012-06-28 : Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 56.9 U/L
  2012-06-28 : Bilirubin.total [Mass/volume] in Serum or Plasma 0.8 mg/dL
  2012-06-28 : Globulin [Mass/volume] in Serum by calculation 2.2 g/L
  2012-06-28 : Albumin [Mass/volume] in Serum or Plasma 4.7 g/dL
  2012-06-28 : Protein [Mass/volume] in Serum or Plasma 6.7 g/dL
  2012-06-28 : Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 19.7 mL/min
  2012-06-28 : Carbon dioxide, total [Moles/volume] in Blood 26.9 mmol/L
  2012-06-28 : Chloride [Moles/volume] in Blood         104.3 mmol/L
  2012-06-28 : Potassium [Moles/volume] in Blood        5.1 mmol/L
  2012-06-28 : Sodium [Moles/volume] in Blood           143.8 mmol/L
  2012-06-28 : Calcium [Mass/volume] in Blood           9.0 mg/dL
  2012-06-28 : Creatinine [Mass/volume] in Blood        2.6 mg/dL
  2012-06-28 : Urea nitrogen [Mass/volume] in Blood     11.3 mg/dL
  2012-06-28 : Glucose [Mass/volume] in Blood           117.6 mg/dL
   
   PROCEDURES:
  2012-07-11 : Combined chemotherapy and radiation therapy (procedure) for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-11 : Hearing examination (procedure)
  2012-07-10 : Combined chemotherapy and radiation therapy (procedure) for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-10 : Hearing examination (procedure)
  2012-07-09 : High resolution computed tomography of chest without contrast (procedure)
  2012-07-09 : Combined chemotherapy and radiation therapy (procedure) for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-09 : Hearing examination (procedure)
  2012-07-08 : Combined chemotherapy and radiation therapy (procedure) for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-08 : Hearing examination (procedure)
  2012-07-07 : Combined chemotherapy and radiation therapy (procedure) for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-07 : Hearing examination (procedure)
  2012-07-06 : Combined chemotherapy and radiation therapy (procedure) for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-06 : Hearing examination (procedure)
  2012-07-05 : Combined chemotherapy and radiation therapy (procedure) for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-05 : Hearing examination (procedure)
  2012-07-04 : Combined chemotherapy and radiation therapy (procedure) for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-04 : Hearing examination (procedure)
  2012-07-03 : Combined chemotherapy and radiation therapy (procedure) for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-03 : Hearing examination (procedure)
  2012-07-02 : Combined chemotherapy and radiation therapy (procedure) for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-02 : Hearing examination (procedure)
  2012-07-01 : Combined chemotherapy and radiation therapy (procedure) for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-07-01 : Hearing examination (procedure)
  2012-06-30 : Combined chemotherapy and radiation therapy (procedure) for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-06-29 : Hearing examination (procedure)
  2012-06-28 : Combined chemotherapy and radiation therapy (procedure) for Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2012-06-28 : Hearing examination (procedure)
   
   IMMUNIZATIONS:
   
   IMAGING STUDIES:
  2012-07-09 : Computed Tomography, Thoracic structure (body structure)
   
--------------------------------------------------------------------------------
CONTINUING
   
   CONDITIONS:
  2011-10-11 : Part-time employment (finding)
  2011-10-11 : Medication review due (situation)
  2011-01-29 : Non-small cell carcinoma of lung, TNM stage 1 (disorder)
  2011-01-28 : Non-small cell lung cancer (disorder)
  2011-01-17 : Suspected lung cancer (situation)
  2002-08-13 : Metabolic syndrome X (disorder)
  2002-08-13 : Hypertriglyceridemia (disorder)
  2001-08-07 : Anemia (disorder)
  2001-08-07 : Diabetes mellitus type 2 (disorder)
  1991-06-11 : Has a criminal record (finding)
  1986-05-13 : Lack of access to transportation (finding)
  1986-05-13 : Essential hypertension (disorder)
  1982-05-04 : Transport problem (finding)
  1982-05-04 : Received higher education (finding)
   
   MEDICATIONS:
  2011-10-11 + lisinopril 10 MG Oral Tablet for Essential hypertension (disorder)
  2011-10-11 + Hydrochlorothiazide 25 MG Oral Tablet for Essential hypertension (disorder)
   
   CAREPLANS:
  2011-01-29 : Terminal care
                         Reason: Non-small cell carcinoma of lung, TNM stage 1 (disorder)
                         Activity: Comfort measures
                         Activity: Chronic pain control management
                         Activity: Cancer education
  2001-08-07 : Diabetes self management plan
                         Reason: Diabetes mellitus type 2 (disorder)
                         Activity: Diabetic diet
                         Activity: Exercise therapy
  1986-05-13 : Lifestyle education regarding hypertension
                         Reason: Essential hypertension (disorder)
                         Activity: Prescribed activity/exercise education
                         Activity: Counseling about alcohol consumption
                         Activity: Dietary approaches to stop hypertension diet
                         Activity: Smoking cessation education
   
--------------------------------------------------------------------------------
